Study: Revlimid interaction may explain side effects

A new trial found Revlimid interacts with P-glycoprotein in a way that affects blood levels of the drug, and the researchers suggest its dosage may need to be tweaked because of their finding. Report

Suggested Articles

Merck’s Keytruda already boasts an OK in some esophageal cancer patients, but it’s looking to widen its reach in the tough-to-treat disease..

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opidivo has broken through with two potentially practice-changing trials.

The custodial measure came after Chinese customs officials raided Genscript’s businesses for “suspected violations of import and export regulations.”